Humacyte Inc (HUMA) — Strategic Asset Allocation Index
Humacyte Inc (HUMA) has a Strategic Asset Allocation Index of 46.7% as of June 2023. Strategic assets (PP&E of $28.54 Million plus long-term investments of $-) total $28.54 Million, measured against net assets of $61.12 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see Humacyte Inc stock valuation.
SAAI
Strategic Assets
PP&E
Net Assets
Humacyte Inc Strategic Asset Allocation Index (2019–2022)
This chart shows how Humacyte Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the index stands at 46.7%, representing strategic assets of $28.54 Million against net assets of $61.12 Million USD. See HUMA equity financing ratio to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for Humacyte Inc (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Humacyte Inc from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore Humacyte Inc (HUMA) equity growth momentum to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 25.7% | $30.04 Million | $30.04 Million | $- | $116.93 Million | ▼ -3.0 pp |
| 2021 | 28.7% | $35.03 Million | $35.03 Million | $- | $122.17 Million | ▼ -205.2 pp |
| 2020 | 233.8% | $165.26 Million | $65.24 Million | $100.02 Million | $70.67 Million | ▲ +178.1 pp |
| 2019 | 55.8% | $73.74 Million | $73.74 Million | $- | $132.20 Million | — |